343 related articles for article (PubMed ID: 21774822)
1. Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study.
Plazak W; Gryga K; Dziedzic H; Tomkiewicz-Pajak L; Konieczynska M; Podolec P; Musial J
Arthritis Res Ther; 2011 Jul; 13(4):R117. PubMed ID: 21774822
[TBL] [Abstract][Full Text] [Related]
2. Lupus Atherosclerosis Prevention Study (LAPS).
Petri MA; Kiani AN; Post W; Christopher-Stine L; Magder LS
Ann Rheum Dis; 2011 May; 70(5):760-5. PubMed ID: 21177297
[TBL] [Abstract][Full Text] [Related]
3. Influence of chronic inflammation and autoimmunity on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients.
Plazak W; Pasowicz M; Kostkiewicz M; Podolec J; Tomkiewicz-Pajak L; Musial J; Podolec P
Inflamm Res; 2011 Oct; 60(10):973-80. PubMed ID: 21744266
[TBL] [Abstract][Full Text] [Related]
4. A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease.
Sdringola S; Gould KL; Zamarka LG; McLain R; Garner J
Am Heart J; 2008 Feb; 155(2):245-53. PubMed ID: 18215593
[TBL] [Abstract][Full Text] [Related]
5. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.
Ardoin SP; Schanberg LE; Sandborg CI; Barnhart HX; Evans GW; Yow E; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; Levy D; von Scheven E; Silverman E; Bowyer SL; Punaro L; Singer NG; Sherry DD; McCurdy DK; Klein-Gitelman M; Wallace C; Silver RM; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Thompson SD;
Ann Rheum Dis; 2014 Mar; 73(3):557-66. PubMed ID: 23436914
[TBL] [Abstract][Full Text] [Related]
6. Use of atorvastatin in systemic lupus erythematosus in children and adolescents.
Schanberg LE; Sandborg C; Barnhart HX; Ardoin SP; Yow E; Evans GW; Mieszkalski KL; Ilowite NT; Eberhard A; Imundo LF; Kimura Y; von Scheven E; Silverman E; Bowyer SL; Punaro M; Singer NG; Sherry DD; McCurdy D; Klein-Gitelman M; Wallace C; Silver R; Wagner-Weiner L; Higgins GC; Brunner HI; Jung L; Soep JB; Reed AM; Provenzale J; Thompson SD;
Arthritis Rheum; 2012 Jan; 64(1):285-96. PubMed ID: 22031171
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial.
Ferreira GA; Navarro TP; Telles RW; Andrade LE; Sato EI
Rheumatology (Oxford); 2007 Oct; 46(10):1560-5. PubMed ID: 17693444
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
[TBL] [Abstract][Full Text] [Related]
10. Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography/computed tomography feasibility study.
Tawakol A; Fayad ZA; Mogg R; Alon A; Klimas MT; Dansky H; Subramanian SS; Abdelbaky A; Rudd JH; Farkouh ME; Nunes IO; Beals CR; Shankar SS
J Am Coll Cardiol; 2013 Sep; 62(10):909-17. PubMed ID: 23727083
[TBL] [Abstract][Full Text] [Related]
11. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
12. Myocardial ischaemia in systemic lupus erythematosus: detection and clinical relevance.
Płazak W; Gryga K; Sznajd J; Pasowicz M; Musiał J; Podolec P
Kardiol Pol; 2011; 69(11):1129-36. PubMed ID: 22090220
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
14. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
15. Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarction: study protocol for a randomized controlled trial.
Rudd N; Subiakto I; Asrar Ul Haq M; Mutha V; Van Gaal WJ
Trials; 2014 Sep; 15():352. PubMed ID: 25195125
[TBL] [Abstract][Full Text] [Related]
16. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.
Arad Y; Spadaro LA; Roth M; Newstein D; Guerci AD
J Am Coll Cardiol; 2005 Jul; 46(1):166-72. PubMed ID: 15992652
[TBL] [Abstract][Full Text] [Related]
17. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.
Nissen SE; Tuzcu EM; Schoenhagen P; Crowe T; Sasiela WJ; Tsai J; Orazem J; Magorien RD; O'Shaughnessy C; Ganz P;
N Engl J Med; 2005 Jan; 352(1):29-38. PubMed ID: 15635110
[TBL] [Abstract][Full Text] [Related]
18. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.
Houslay ES; Cowell SJ; Prescott RJ; Reid J; Burton J; Northridge DB; Boon NA; Newby DE;
Heart; 2006 Sep; 92(9):1207-12. PubMed ID: 16449511
[TBL] [Abstract][Full Text] [Related]
19. Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.
Kiani AN; Post WS; Magder LS; Petri M
Rheumatology (Oxford); 2011 Nov; 50(11):2071-9. PubMed ID: 21875880
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.
van Leuven SI; Mendez-Fernandez YV; Wilhelm AJ; Wade NS; Gabriel CL; Kastelein JJ; Stroes ES; Tak PP; Major AS
Ann Rheum Dis; 2012 Mar; 71(3):408-14. PubMed ID: 21953346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
